Vyome Therapeutics is working to treat inflammatory diseases using locally-acting, novel and next generation therapeutic solutions with validated mechanisms of action and effective formulations for site-targeted applications. With this approach to drug development, Vyome is working to develop safer and more effective alternatives to standards of care in multifactorial diseases of high unmet need which are underpinned by inflammation.
Vyome Therapeutics Strengthens Executive Management with Appointment of Craig Tooman as Chief Operating Officer and Chief Financial OfficerView More
Read More to know about Vyome's Vision and PlansView More
Read More to know about Vyome's innovative and patented technology platforms for partnering opportunitiesView More
Read More to know about Vyome's pipeline of novel products developed using breakthrough technology platforms, and available for partneringView More
Team with expertise, demonstrated capability and track record of launching 50+ drugsView More
Read More to discover Partnering opportunities with Vyome on technology platforms and productsView More
Copyright © 2015 Vyome Therapeutics Inc. All rights reserved.